- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 3/08 - Drugs for disorders of the metabolism for glucose homeostasis
Patent holdings for IPC class A61P 3/08
Total number of patents in this class: 1236
10-year publication summary
|
46
|
82
|
110
|
105
|
94
|
108
|
71
|
107
|
93
|
44
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3175 |
23 |
| The Board of Trustees of the Leland Stanford Junior University | 6652 |
16 |
| Boehringer Ingelheim International GmbH | 4502 |
14 |
| Axcess Global Sciences, LLC | 92 |
14 |
| TNF Pharmaceuticals, Inc. | 19 |
11 |
| The Regents of the University of California | 20694 |
10 |
| Amgen Inc. | 4418 |
10 |
| The Trustees of Columbia University in the City of New York | 3638 |
10 |
| Alla Chem, LLC | 51 |
9 |
| Eli Lilly and Company | 4084 |
9 |
| Société des Produits Nestlé S.A. | 10097 |
8 |
| Sanofi-Aventis Deutschland GmbH | 2593 |
8 |
| Novo Nordisk A/S | 2284 |
8 |
| Takeda Pharmaceutical Company Limited | 2713 |
7 |
| Amylyx Pharmaceuticals Inc. | 125 |
7 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3339 |
7 |
| Nanjing Nutrabuilding Bio-Tech Co., Ltd. | 271 |
7 |
| Regeneron Pharmaceuticals, Inc. | 4689 |
7 |
| Atrogi AB | 57 |
6 |
| Hanmi Pharm. Co., Ltd. | 601 |
6 |
| Other owners | 1039 |